Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06604871 · ClinicalTrials.gov registry record · NA
Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT06604871: Completed NA study, sponsored by Medtronic MiniMed.
NCT06604871 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06604871, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 pediatric subjects (2-6 years of age) in a home setting.
Primary Outcome
Percent of Time in Range (TIR 70-180 mg/dL). Descriptive only.
Interventions
- DEVICE Insulin Pump with Continuous Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2025-09-26 |
| Phase | NA |
What the finished NCT06604871 record still lists
NCT06604871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Insulin Pump with Continuous Glucose Monitoring is the first listed.
NCT06604871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06604871 about?
NCT06604871 is a clinical study titled "Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children". The purpose of this study is to evaluate the safety of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 pediatric subjects (2-6 years of age) in a home setting.
What is the current status of trial NCT06604871?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2024-10-29. Estimated completion is 2025-09-26.
What interventions are being tested in trial NCT06604871?
The interventions under investigation include: Insulin Pump with Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT06604871?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06604871's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI